ÂÒÂ×Ðã

Describing work published in the journal Neuropharmacology, Professor Matthew Walker (ÂÒÂ×Ðã Institute of Neurology) says: "This offers a whole new approach to the treatment of drug-resistant epilepsies in children and adults."